行情

CDXC

CDXC

ChromaDex
NASDAQ

实时行情|Nasdaq Last Sale

3.150
+0.200
+6.78%
盘前: 3.150 0 0.00% 07:59 03/31 EDT
开盘
2.990
昨收
2.950
最高
3.180
最低
2.960
成交量
626
成交额
--
52周最高
4.950
52周最低
2.500
市值
1.88亿
市盈率(TTM)
-5.5891
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CDXC价格均价为7.38,最高价位10.50,最低价为6.00。

EPS

CDXC 新闻

更多
  • 美元的赌命时刻
  • 新浪财经-自媒体综合 · 1小时前
  • 沙特4月将全面宣战俄罗斯 全球产量损失可能达500万桶/日
  • 新浪财经综合 · 2小时前
  • Cowen主席:新冠疫情成为“已知的未知”,尽量让行动慢下来
  • 新浪财经 · 3小时前
  • 印尼央行行长:东南亚国家中央银行正在协调经济刺激行动
  • 新浪财经 · 3小时前

所属板块

生物技术和医学研究
+4.00%
制药与医学研究
+4.75%

热门股票

代码
价格
涨跌幅

CDXC 简况

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
展开

微牛提供Chromadex Corp(NASDAQ-CDXC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CDXC股票新闻,以帮助您做出投资决策。